ProCE Banner Activity

Express Points

Aggressive B-Cell Lymphomas: Experts Discuss New Care Standards and Evolving Treatment Strategies

Slideset Download

Download this short summary slideset covering the key points from a live symposium to gain more insight into the diagnosis and optimal management of MCL and DLBCL.

Released: December 16, 2022

Expiration: December 15, 2023

No longer available for credit.

Share

Faculty

John P. Leonard

John P. Leonard, MD

Chief, Lymphoma/Myeloma Service
Division of Hematology and Oncology
Weill Medical College of Cornell University
New York Presbyterian Hospital
New York Weill Cornell Center
New York, New York

John N. Allan

John N. Allan, MD

Associate Professor of Clinical Medicine
Division of Hematology and Medical Oncology
Weill Cornell Medicine
New York, New York

Laurie H. Sehn

Laurie H. Sehn, MD, MPH

Chair, Lymphoma Tumour Group
BC Cancer
Vancouver, Canada

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Bristol Myers Squibb

Genmab US Inc and AbbVie

Karyopharm Therapeutics Inc.

Regeneron Pharmaceuticals, Inc.

Target Audience

This educational program is intended for medical oncologists and other healthcare professionals who treat patients with B cell lymphomas.

Program Director Disclosure

Program Director

John P. Leonard, MD

Chief, Lymphoma/Myeloma Service
Division of Hematology and Oncology
Weill Medical College of Cornell University
New York Presbyterian Hospital
New York Weill Cornell Center
New York, New York

Faculty Disclosure

Primary Author

John N. Allan, MD

Associate Professor of Clinical Medicine
Division of Hematology and Medical Oncology
Weill Cornell Medicine
New York, New York

John N. Allan, MD: consultant/advisor/speaker: AbbVie, Adaptive Biotechnologies, ADC Therapeutics, AstraZeneca, BeiGene, Genentech, Janssen, Lava, Lilly, Pharmacyclics; researcher: BeiGene, Genentech.

Laurie H. Sehn, MD, MPH

Chair, Lymphoma Tumour Group
BC Cancer
Vancouver, Canada

Format

This program has been made available online.

Additional Information

Participation in this self-study activity should be completed in approximately 2.0 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from January 30, 2023, through January 29, 2024:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.